Conference Coverage
Conference Coverage
Relapsed MCL: Options for treatment
There are a number of treatment options for relapsed MCL, but BTK inhibitors are particularly useful.
Conference Coverage
Risk of cancer in NAFLD is 91% higher than in control subjects
SAN FRANCISCO – The observed increase is highest in gastrointestinal cancer subjects.
Conference Coverage
Preop anemia management saves blood, costs
BOSTON – Managing anemia prior to cardiac surgery saved a hospital more than $100,000 in transfusion costs in a pilot program.
Conference Coverage
Early phase 2 data: Mocetinostat/durvalumab combo shows promise in mNSCLC
WASHINGTON, D.C. – Mocetinostat/durvalumab shows activity and manageable AEs in metastatic NSCLC after progression...
Conference Coverage
Scleroderma SCOT trial findings hold similar in lung disease
CHICAGO –
Conference Coverage
Consider treatment, testing when CLL symptoms emerge
CHICAGO – Predictive tests should be conducted before beginning therapy.
Conference Coverage
Palliative-rehab combo may improve QoL in newly diagnosed cancer patients
Patients in the rehabilitative palliative care program that included individualized palliative care consultations and a patient/caregiver “school...
Conference Coverage
CLL: The initial work-up
CHICAGO – Molecular testing has prognostic value, but still doesn’t drive treatment under updated iwCLL guidelines.
Conference Coverage
Abiraterone also benefits low-risk metastatic prostate cancer patients
MUNICH – Analyses of STAMPEDE trial data using risk criteria from two other trials revealed distinct survival benefits with abiraterone, ADT, and...
Conference Coverage
Prognostic features could improve ALL outcomes
CHICAGO – Cytogenetic factors, minimal residual disease activity, and Philadelphia chromosome–like signature are among the features with...
Conference Coverage
PBM saves blood, costs in HSCT unit
BOSTON – Blood-product use declined, with no negative effects on patients outcomes, following the start of a patient blood management program.